A Multicenter, Double-blind, Placebo-controlled Randomized Clinical Trial Comparing Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With Ascites : Using or Not Using Rifaximin
Latest Information Update: 12 Apr 2025
At a glance
- Drugs Rifaximin (Primary)
- Indications Bacterial peritonitis
- Focus Therapeutic Use
- Acronyms ProPILARifax
Most Recent Events
- 20 Aug 2024 New trial record